Highly sensitive determination of saquinavir in biological samples using liquid chromatography–tandem mass spectrometry
- 5 February 2003
- journal article
- Published by Elsevier in Journal of Chromatography B
- Vol. 784 (2) , 233-242
- https://doi.org/10.1016/s1570-0232(02)00803-6
Abstract
No abstract availableKeywords
Funding Information
- Bundesministerium für Bildung und Forschung
This publication has 23 references indexed in Scilit:
- Dose‐dependent increase of saquinavir bioavailability by the pharmaceutic aid cremophor ELBritish Journal of Clinical Pharmacology, 2002
- The role of therapeutic drug monitoring in treatment of HIV infectionBritish Journal of Clinical Pharmacology, 2001
- Drug Resistance and Predicted Virologic Responses to Human Immunodeficiency Virus Type 1 Protease Inhibitor TherapyThe Journal of Infectious Diseases, 2000
- Simultaneous determination of the HIV-protease inhibitors indinavir, nelfinavir, saquinavir and ritonavir in human plasma by reversed-phase high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1999
- Therapeutic Drug Concentration Monitoring Using Saliva SamplesClinical Pharmacokinetics, 1999
- Grapefruit juice enhances the bioavailability of the HIV protease inhibitor saquinavir in manBritish Journal of Clinical Pharmacology, 1998
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- SaquinavirDrugs, 1996
- Quantification of the anti‐HIV drug saquinavir by high‐speed on‐line high‐performance liquid chromatography/tandem mass spectrometryJournal of Mass Spectrometry, 1995
- Analytical Methods Validation: Bioavailability, Bioequivalence, and Pharmacokinetic StudiesJournal of Pharmaceutical Sciences, 1992